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Abstract: 
The purpose of this study was to optimize the best granulation techniques for development of tablet dosage form. 
The present study explains comparative study of different wet granulation techniques including Planetary mixer 
granulation, Rapid mixer granulation, Fluid bed granulation with Direct compression method. Similar 
formulations were used to evaluate Planetary mixer granulation, Rapid mixer granulation and Fluid bed 
granulation method. The granules prepared by different techniques were evaluated for particle size distribution, 
porosity, spherisity, bulk density, flow property and compressibility, compatibility and tablet properties of 
Diclofenac sodium tablet. The fluid bed granulation technique had superior flow properties, compressibility, 
compactibility measured by Kawakita, Hekel, Walker and Leuenberger equation. The granules prepared by 
Fluid bed granulation showed better tablet properties (weight uniformity, hardness, friability and 
disintegration, drug content, dissolution) and accelerated stability study compared to other granulation 
techniques so finally, it was concluded that Diclofenac sodium tablets prepared by using fluid bed granulation 
which meets the required specification compared to other wet granulation techniques and direct compression 
method. 
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INTRODUCTION: 
Most product formulators see wet granulation 
technology as a universally applicable means of 
tablet processing.  The wet granulation techniques 
to be most preferred due to various advantages 
including improving flow property, compression 
characteristics, better distribution of colour and 
reduces dust hazards. So that to optimize the best 
wet granulation technology is important for 
development of tablet dosage form. Direct 
compression is one of the popular methods for 
preparation of tablet However, it is often necessary 
to improve poor content uniformity, flowability, 
compression and compactibility to produce tablet 
of adequate quality. These properties are 
commonly enhanced by wet granulation.[1] Wet 
granulation is widely used process of granulation in 
the pharmaceutical industry. It involves addition of 
a liquid solution (with or without binder) to 
powders, to form a wet mass. The wet mass is dried 
and then sized to obtained granules. The liquid 
added binds the moist powder particles by a 
combination of capillary and viscous forces in the 
wet state. More permanent bonds are formed 
during subsequent drying which leads to the 
formation of agglomerates.[2] This can be achieved 
by using Planetary mixer granulation, Rapid mixer 
granulation and Fluid bed granulation. Fluid bed 
granulation has some advantages compared to other 
granulation method. . Fluid bed granulation method 
is selected for production of porous and free-
flowing granules, which enables to form tablets 
with high mechanical strength at low compression 
pressure. Simultaneous granulation and drying 
removes the need for additional drier and all 
granulation process performed in one unit so saving 
time, transfer losses and labour costs.[3] 
 
Kawakita analysis revealed improved flowability 
for formulations prepared by direct compression 
and wet granulation technique. Compressibility is 
the powder’s ability to deform under pressure, and 
compactibility is the ability to form mechanically 
strong compacts. Compressibility is often described 
by the change in the relationship between relative 
density, porosity and applied pressure represented 
by heckle and walker models. [8] Compactibility is 
nonlinear plot of tensile strength with respect to 
product of compaction pressure and relative density 
represented by Leuenberger equation.4Litrature 
addresses each type of granulation process 
individually and in detail.[5] Comparison was 
found between a low shear, high shear, and fluid 
bed granulation during low dose tablet process 
development.[6] A Comparison was also found 
between the different granulation techniques for 
Lactose Monohydrate.[7]  Another reference 
compared impact of wet and dry granulation versus 
a direct tableting mixer and a compressibility and 
compactibility study of real tableting mixtures.[8] 
The purpose of study was to investigate the effect 
of planetary mixer granulation, Rapid mixture 
granulation and Fluid bed granulation on 
granulation properties like particle size distribution, 
porosity, spherisity, bulk density, flow property and 
compressibility, compatibility, tablet properties and 
accelerated stability study of Diclofenac sodium 
tablet and based on above evaluation parameter to 
optimize the best granulation techniques for 
development of tablet dosage form.[9,10,11] 
 
1. MATERIALS AND METHODS: 
1.1 Materials 
The mixture consisted of Diclofenac sodium 
(model drug, Neon labs Ltd Palghar, India), 40% 
(W/W); lactose monohydrate (Filler, Pharmatose 
350M for wet granulation,41.3% (W/W); lactopress 
spray dried-250 for direct compression, 43.12 % 
(W/W);DFE Pharma India, LLP, Bangalor), 
microcrystalline cellulose (Filler/ dry binder, 
Avicel PH 101, VerGo Pharma Research 
Laborataries Pvt. Ltd, Goa) 13.7%(W/W); 
polyvinylpyrrolidone (binder, Povidone K90, 
BASF India Ltd., Navi Mumbai) 2.5% (W/W); 
Crosspovidone  (disintegrating agent, Research 
Fine Lab, Mumbai) 2% (W/W);and magnesium 
stearate (Lubricant, BASF India Ltd., Navi 
Mumbai) 0.5% (W/W) etc. [All chemicals used 
were of analytical grade.] 
 
2.2 Characterization of Diclofenac 
sodium 
The organoleptic properties of drug were 
determined including nature, color, solubility. 
Melting point: The melting point was determined 
by using open capillary method. 
 
2.3.2 FTIR Spectroscopy 
IR Spectrum interpretation 
The infrared absorption spectrum of pure 
Diclofenac sodium was recorded on FT-IR 
Spectrophotometer (Model- Agilent) and the 
spectrum analysis was done for functional 
groups.[12] 
 
2.3.3 X-ray Diffractometry 
The X-ray diffraction patterns of drug were 
determined using a Bruker D2 Phaser powder X-
ray diffractometer. Samples were irradiated with 
monochromatized CuK alpha radiation (1.542 A0) 
and analyzed between 10 and 70 (2ϴ) at a scan rate 
of 0.1° 2θ per min. [12] 
 
2.3.4 Drug - Excipients compatibility studies of 
physical mixture 
The infrared absorption spectrum of pure 
Diclofenac sodium and physical mixer of drug and 
excipients was recorded on FT-IR 
Spectrophotometer (Model- Agilent) The IR 
spectroscopy was used to investigate and predict 
IAJPS 2017, 4 (12), 4626-4639                     V. B. Khot et al                        ISSN 2349-7750 
 w w w . i a j p s . c o m  
 
Page 4628 
any physiochemical interaction between drug and 
different excipients. 
 
2.3.5 X-ray diffractometry of drug, excipients 
and formulation 
The X-Ray diffraction study was conducted for 
evaluation of change in crystalline nature of pure 
drug by process or addition of other polymers. The 
sample was analyzed by using Brooker D2 Phaser 
powder X-Ray Diffractometer and was scanned 
from 10° to 70° 2θ. 
 
2.4 Preparation of granules  
Granules were prepared according to the 
procedures enumerated and described below. 
Before preparation of granules, all materials were 
sieved manually through a sieve with a mesh size 
of 0.8 mm. The weighted amounts of powders were 
the same for all mixtures: Diclofenac sodium 
(100gm), Pharmatose 350M (103.5gm), Avicel PH-
101 (34.25gm), PVP K-90 (6.25gm), 
Crosspovidone (5gm).[8] 
 
2.4.1. Planetary mixer granulation (PMG) 
Weighted powders without PVP-K 90 were mixed 
in a mixing bowl of planetary mixer granulator 
(Kenwood, Kolkata, India).  All ingredients were 
mixed at low speed then 5% binder was added then 
mixture was mixed at high speed. With the help of 
wet mass consistency and physical properties of 
granules end point of granules was determined. 
Wet granules were sieved using a sieve with a 
mesh size 16 ≠. Then granules were transferred to 
the fluid-bed dryer and dried at an inlet air 
temperature 600C and air flow of 60 rpm. Drying 
lasted for 40 min. after that dried granules were 
sieved using a sieve with a mesh size of 30≠. 
2.4.2. Rapid mixer granulation (RMG) 
Weighted powders were mixed with a Rapid mixer 
granulator for 2 min at an impeller speed of 150 
rpm. 4.5 % binder was added into the mixed 
ingredients and then granulate was kneaded for 180 
s. at an impeller speed of 250 rpm and the chopper 
speed of 2500 rpm. With the help of wet mass 
consistency and physical properties of granules end 
point of granules was determined .Wet granules 
were sieved using a sieve with a mesh size 16 ≠. 
Then granules were transferred to the fluid-bed 
dryer and dried at an inlet air temperature 600C and 
air flow of 60 rpm. Drying lasted for 40 min. Dried 
granules were sieved using a sieve with a mesh size 
of 30≠. 
 
2.4.3. Fluid bed granulation (FBG) 
Weighted powders without PVP-K-90 were mixed 
in a fluid bed processor (Pam glatt,  Mumbai) The 
parameter was set like process time-420 min, pouse 
time-40 sec, shaking time-10 sec, shaking speed-
500 msec. Then 8.33% (w/w) aqueous solution of 
PVP-K-90 was sprayed. After that the parameter 
was set like Inlet temperature 500C, Product 
temperature 400C, exhaust temperature 500C, 
atomization air-1.1 bar, blower drive speed-14%, 
air flow 130 cfm, spray pump speed 14 rpm and 
spray rate 10 gm/min. At the end point the product 
temperature was 540C and inlet air temperature was 
700C. The moisture content of granules during the 
operation was continuously monitored. The 
operating conditions such as inlet air temperature 
and airflow rate were controlled during granulation. 
Then the granules were passed through 30# and 
lubricated with Mg-stearate. 
 
2.4.4. Mixture for direct tableting (DC) 
Weighted Diclofenac sodium(100gm), Lactopress 
spray dried- 250 (107.8gm), Avicel PH 
101(35.95gm), Crosspovidone (5gm) were mixed 
for 10min. Magnesium stearate (1.25gm) was  
added then mixing for 2 min was performed. 
 
2.5 Evaluations of granules 
2.5.1 Moisture content 
Five grams (5g) of each powder sample was 
accurately weighed and dried at 105°C in the oven 
to constant weight. The sample was reweighed and 
weight loss calculated.[13] 
 
2.5.2 Particle size distribution 
The particle size distribution for all mixtures (50 g 
sample) was determined by sieve analysis using 
vibrating shaker using the following sieves size 
(µm): 500, 355, 250, 180and 150. The sieving 
lasted for 10 min. Results was represented as 
particle size distribution and also as the particle 
size at which 50% (w/w) of particles were below 
the given size denoted as median particle diameter 
d50.[7,8,15] 
 
2.5.3 Span value of granules [14] 
Span value determined by using sieving method. 
Span value was calculated by using d10, d50 and 
d90 values 
 
 
 
 
Where,      d90 =90% of particles are below the 
particle diameter 
d10 = 10% of particles are below the particle 
diameter 
d50 = median particle diameter 
 
2.5.4 Particle shape [5,7] 
Motic microscope (Optical microscope with 
cammera motic image plus version, 2.0 MI) was 
used to determine the shape of granule. By using 
Motic microscope radius, perimeter and area of 
granule was determined. The Form factor was used 
to determine the sphericity of granules. Form factor 
was calculated by using following formula 
 
 
IAJPS 2017, 4 (12), 4626-4639                     V. B. Khot et al                        ISSN 2349-7750 
 w w w . i a j p s . c o m  
 
Page 4629 
 
     
     
   
 
2.5.5 Bulk and tapped densities 
Bulk Density and Tap Density were subjected to 
Bulk and Tap density determination. Tapping 
cylinder method was used for determining bulk and 
tap density of granules were taken in 10 ml 
measuring cylinder. Initial volume (Bulk volume) 
and the volume after 100 tapings (Tap volume)  
were measured.  From the results of Bulk  and Tap 
densities, the Hausner’s   ratio   and   Carr’s   Index   
were   calculated.[7] 
 
2.5.6 Flow properties of tableting mixture 
[16,18] 
 
The flowability was determined by measuring the 
Carr’s index, and Hausner’s ratio, angle of repose, 
flow time. 
 
The bulk and tapped densities were used to 
determine the Carr’s index, and Hausner’s ratio. 
The Carr’s index and Hausner’s ratio were 
calculated according to following equations 
 
  
 
  
 
 
 
 
 
1. Angle of repose: The end of a funnel was placed 
2 cm above a flat base. Powder was filled into the 
funnel, so that after releasing the powder out of the 
funnel the top of the resulting cone reached the end 
of the funnel. The powder was released from the 
funnel. From the height of the cone(h) and the 
diameter at the base (d) the angle at the base, the 
angle of repose, (α) was determined. 
 
 
 
 
 
2. Flow rate: 10 gm of granule was placed in funnel 
and time was measured to flow of granules from 
the funnel.  Flow rate were determined as the ratio 
of mass (g) to time (seconds) using a steel funnel 
with an orifice diameter of 10 mm. 
 
 
 
 
 
 
2.5.7 Bulkiness [17] 
Bulkiness is determined by using specific bulk 
volume or bulk density. Bulkiness determined by 
using following formula 
 
 
 
 
2.5.8Porosity of granules [17] 
Porosity is the ratio of void volume to the bulk 
volume. The void volume is calculated by using 
following formula 
 
 
 
 
 
Porosity is expressed in percentage so the porosity 
was calculated by using following formula 
 
 
 
 
 
2.5.9 Kawakita plot 
Flowability was determined using the Kawakita 
analysis. 
 
The formulation (10) gm was poured into a   50 ml 
glass measuring cylinder. The heaped particles in 
the cylinder were then levelled off horizontally and 
the bulk volume Vo was accurately measured. 
Tapping was afterwards initiated mechanically and 
the change in volume of the powder column VN   
was noted after N no. of tap. The Kawakita 
equation is given by: 
 
 
 
 
Where a and bare constants; a describes the degree 
of volume reduction at the limit of tapping and is 
called compactibility; 1/b is called cohesiveness, 
C, the degree of volume reduction is calculated 
from the initial volume Vo and tapped volume VN 
as 
 
 
 
 
Numerical values for constants aand 1/bwas obtained 
from the slope, of plots of N/C versus number of taps 
N.18 
 
2.6 Formulation of Diclofenac sodium tablet 
1. Wet granulation method: The granules were 
mixed with 0.5% Mg-stearate 
2. Direct compression method: Mixture for direct 
tableting was used 
 
 
 
 
 
 
 
 
Void volume (v) = v bulk (untapped)-v true (tapped) 
Porosity ( = 100 
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2.7 Compaction studies [8] 
2.7.1 Heckel plot 
Preparation of compacts: 250mg Diclofenac 
sodium tablet were made using 10Kg/cm2 to 
120Kg/cm2 compression pressures in KBr pellet 
press machine. Compacts were made at each 
compression level. Before compression, the die and 
the flat-faced punches were lubricated Mg-stearate. 
The hardness, dimensions and weight of compacts 
were determined. The relative density was 
calculated as the ratio of apparent density of the 
compact to the true density of the powder. The data 
obtained using this ‘ejected tablet method’ was 
used to obtain Heckel plots. 
 
Heckel Analysis: 
The Heckel model was based on the assumption 
that the process of pore reduction during 
compression. The degree of compact densification 
with increasing compression pressure is directly 
proportional to the porosity as follows: 
 
 
 
 
 
Where, D is the relative density of the compact,  P 
is applied pressure, K (slope; Heckel coefficient), 
K is the slope of the straight portion of the graph, 
reflects the reduction in porosity or the resistance 
to volume reduction of granules and A (y-intercept) 
are regression coefficients of the linear portion of 
the curve, and ε is porosity. Yield pressure (Py), 
which is the reciprocal value of the slope (K) of the 
Heckel plot was a measurement of the material’s 
compressibility. Greater slopes indicate a greater 
degree of plasticity hence better compressibility of 
the material. 
 
2.7.2 Walker plot 
The Walker equation plots the specific volume of 
the powder compact against the logarithm of the 
axial pressure applied 
 
 
 
where V’ is the specific volume of a tablet and w’ 
is the Walker coefficient expressing the volume 
reduction corresponding to one decade change in 
pressure P obtained by linear regression analysis, 
and V’ sp is the specific volume at pressure 1. 
 
2.7.3 Leuenberger Equation 
The compression susceptibility parameter for 
compact formed by direct compression and wet 
granulation technique indicated that the maximum 
crushing strength is reached faster at lower pressure 
of compression 
For compactability assessment, tensile strength of 
the compacts was calculated by the following 
equation where x is hardness (in kg/cm2) and d and 
t are the diameter and thickness of the compacts (in 
mm), respectively. 
 
 
 
 
Leuenberger analysis was performed by fitting the 
data in the following equation. A nonlinear plot of 
tensile strength with respect to product of 
compaction pressure P and relative density was 
obtained. 
 
 
 
 
Where, x maxis maximum tensile strength (kg/cm2), 
p will be infinite and will be equal to 1, and γ is 
compression susceptibility.[18] 
 
2.8 EVALUATION OF TABLETS 
2.8.1 Thickness 
Thickness of tablet was determined using 
calibrated Vernier caliper.[20] 
 
2.8.2 Hardness 
For each formulation, the hardness of six tablets 
was determined using the Pfizer hardness tester. 
The tablet was held along its oblong axis in 
between the two jaws of the tester. At this point, 
reading should be zero kg/cm2. Then constant force 
was applied by rotating the knob until the tablet 
fractured. The optimum hardness regarded for 
uncoated tablet is 4-6 kg/cm2.[19] 
 
2.8.3 Weight variation test 
Randomly selected twenty tablets were weighed 
individually and together. Average weight was 
calculated. Each individual tablet weight was 
compared against the calculated average.[19] 
 
2.8.4 Friability test19 
The friability of a sample of 6 tablets was measured 
using a Roche friabilator (Remi electronics, 
Mumbai). 6 previously weighed tablets were 
rotated at 25 rpm for 4 min. The tablets were 
dedusted and again weighed. A loss of less than 1 
% in weight is generally considered acceptable. 
Percent friability was calculated as follows 
 
 
 
 
2.8.5 Drug content 
The tablets were finely powered and a quantity of 
powder equivalent to 100mg of diclofenac sodium 
were accurately weighed and transferred to 100ml 
volumetric flasks containing approximately 50ml 
of buffer solution (pH6.8) and analysed for the 
content of diclofenac sodium using UV-visible 
 
 
 
 
 
 
 
V’=w’log P+V’sp 
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spectrophotometer at 276nm. The drug content of 
each sample was estimated.[20] 
 
2.8.6 Disintegration test 
The disintegration time of the uncoated tablet was 
performed with help of disintegration test apparatus 
using phosphate buffer (pH 6.8) media at 370C ± 
0.50C. The time taken for six randomly selected 
tablets to disintegrate in each case was 
recorded.[21] 
 
2.8.7 In-vitro drug release studies 
In-vitro drug release study of Diclofenac sodium 
was done by using USP dissolution test apparatus 
II. The study was conducted at 50 rpm using 900 
ml of pH 6.8 phosphate buffer maintained at 370C-
0.50C by using a constant temperature bath. The 5 
ml sample was withdrawn from the dissolution 
apparatus at 10 min time intervals up to 60 min. the 
sample were replaced with fresh dissolution 
medium and then absorbance was measured by 
using UV-visible spectrophotometer at λmax of 
276 nm. Cumulative percentage drug release was 
calculated using an equation obtained from a 
standard curve. The graphs of % cumulative release 
Vs time were plotted.[21] 
 
2.9 Stability study of tablets 
Samples of Diclofenac sodium   tablets were blister 
packed in aluminum foil. These samples were then 
subjected for stability study according to ICH 
guidelines where zone II was selected as storage 
conditions (ICH 2003). Tests were conducted at 
room temperature (RT) and accelerated stability 
conditions. The samples were designated as time 0, 
3, 6, 9, 12, 18 and 24 months for RT and 0, 1, 2, 3 
and 6 month for accelerated studies. Samples 
designed for RT storage were kept at 25±2°C and 
60±5% relative humidity (RH). The samples in the 
accelerated stability study were kept at 40±2°C and 
75±5% RH in humidity chamber. Samples were 
tested for its appearance, disintegration, dissolution 
and assay using the previously described procedure 
to evaluate the stability of   tablets. The percent 
dissolution, assay, appearance and hardness of the 
tablets stored at room temperature for 24 
months.[21] 
 
3. RESULT AND DISCUSSION: 
3.1 Characterization of drug 
The powder was found to be White to slightly 
yellowish, slightly hygroscopic, crystalline powder. 
Diclofenac sodium is soluble in ethanol, methanol 
and water. The melting point was found in the 
range of 284-285 0C.  All observed parameters was 
found to be similar and complies with the standard 
specifications. Hence the drug sample was 
considered as a pure. 
 
3.1FTIR Spectroscopy 
The IR spectrum (Figure 1) of the Diclofenac 
sodium showed similar characteristics peaks to that 
of reported spectra of Diclofenac sodium. From the 
FTIR study the sample of Diclofenac sodium was 
identified.
 
 
Fig. 1: FTIR Spectra of Diclofenac sodium 
 
 
Fig. 2: XRD of pure Diclofenac sodium 
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3.2 X-ray diffractometry: 
The X-Ray diffraction patterns of pure Diclofenac 
sodium were illustrated in Figure 5The 79.8% of 
drug was found to be in crystalline form 20.2% was 
in amorphous form. 
The characteristic peaks of Diclofenac sodium 
appeared at a diffraction angle of 20.180at 
maximum intensity of 2527 and several sharp 
diffraction peaks suggesting that the drug is present 
in crystalline form. 
 
3.3 Drug and polymer compatibility 
3.1.1 FTIR spectroscopy 
The IR spectra of drug and physical mixture show 
similar characteristic functional peaks. This 
similarity in peaks indicates the compatibility of 
Diclofenac sodium with the excipients. 
 
 
Fig.3: IR spectra of drug and physical mixtur of  pharmatose 350M  
 
Fig. 4: IR spectra of drug and physical mixture of Avicel PH 101 
 
3.1.2 X- ray diffractometry of drug, excipient 
and formulation 
TheFigure8, 9shows non-interactive peaks of pure 
drug, excipients like Pharmatose 350M,Avicel PH 
101 and formulation was showed characteristic 
sharp peak in the range of 2ϴ scattered. The 
decrease in the peak intensity was observed in 
formulation. 
 
Fig. 5: XRD of Diclofenac sodium,  Pharmatose 350M and F2 formulation 
 
 
 
Fig. 6: XRD of Diclofenac sodium, Avicel PH 1O1 and F2 formulation 
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3.4 Formulation of granules 
Wet granulation method was used for preparation 
of granules. PMG, RMG and FBG were used for 
preparation of granules. 
 
3.5 Evaluation of granules 
3.5.1 Moisture content 
Loss on drying is known that the moisture content in 
granules or powders can influence the hardness and 
therefore compactibility of the tablets produced. 
Therefore, all tableting mixtures produced were 
dried to an approximately equal moisture level. It 
was established that the loss on drying (LOD) values 
of the tableting mixtures produced were the 
following: PMG 1.50%, RMG 1.75%, FBG 1.65%, 
and DC 1.25%. All LOD values are within the range 
of 1.25–1.75% and may be considered comparable 
or approximately equal because it is known that 
moisture content is difficult to control during drying 
processes of pharmaceutical materials, especially 
when drying wet granules in narrow ranges such as 
±0.1%. Similar batch-to-batch variability in LOD 
values are commonly observed for regular 
pharmaceutical intermediate products such as 
granulates and tableting mixtures. 
 
3.5.2 Particle size distribution 
Tableting mixtures were prepared using different 
granulation methods PMG, RMG, FBG and DC 
The particle of PMG(P2), RMG(R2), FBG(F2) 
mixtures were considerably d50 values of around  
342µm, 350µm, 409µm, respectively and  particles 
of the DC (D1)  mixtures were considerably 
smaller, with d50 values of around 93.75µm.  
Larger particles in the size range of 125–1250 µm. 
The larger particle size of agglomerates compared 
with the DC mixture is expected due to the 
granulation process. 
 
 
Fig.7: Cumulative mass distribution of compression mixtures  
 
A good powder formulation has a uniform particle 
size distribution. If the particle size distribution 
was not uniform, the powder can segregate 
according to the different particle sizes. A uniform 
particle size distribution insures uniform 
dissolution rate, compaction process and 
flowability, so it was important to evaluate these 
parameters. Thus, in order to compare the mixtures, 
a numerical particle size was given as the median 
particle diameter d50. 
 
3.5.3 Span value of granules: 
Lowest span value shows the narrow particle 
size distribution. Here FBG showed lowest span 
value so the FBG showed narrow particle size 
distribution compare with PMG, RMG and DC 
method. 
 
Fig. 8: Span value of granules 
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Form factor of granules: 
Formfactor gives a measure of sphericity and a 
perfect sphere has a formfactor value of unity.FBG 
showed formfactor value of unity so that FBG have 
high sphericity compare to the RMG, PMG and DC 
method. If the particles have more sphericity then 
flow rate of granule decreases. FBG showed the 
less flow rate because the sphericity of granules. 
Table 1: Form factor of granules 
Granulation 
batches 
P2 R2 F2 D1 
Form factor 0.6866 0.5929 1.000 0.999 
In case of direct compression have also same 
formfactor value of unity because lactopress spray 
dried-250 a direct compressible vehicle present in 
to DC method. 
Bulk density 
After granulation bulk density of FBG was 
decreased compare to RMG, PMG and DC method. 
FBG showed decreases in bulk density with 
increase in granule voidage but in case of RMG 
bulk density increase during kneading step. The 
void between granules was compressed and granule 
densify. PMG cannot compress the voids between 
granules so that bulk density of PMG was 
intermediate in value between those of FBG and 
RMG. PMG produce fluffier, more porous granules 
than RMG. The bulk density of fluid bed 
granulation is decrease compare to direct 
compression.  
 
Tapped density of FBG was less compare to RMG, 
PMG and DC   method. The tableting mixture 
density obviously plays an important role in 
powder compressibility. 
 
3.5.6 Flow properties of tableting mixture 
The flow properties results are shown in Table 6, 7 
and 8. The flow propertiesas dictated by the Carr 
index, the Hausner ratio, Angle of repose and the 
flow time are entirely consistent with one other. 
Ingeneral, flow properties of wet granulated 
mixtures are superior to other mixtures.FBG shows 
excellent flow property. The RMG, PMG and DC 
method shows good flow property. DC mixture 
shows good flow properties due to the usage of 
directly compressible main component of the 
formulation. 
 
 
Fig. 9: Bulk density of granules after granulation 
 
Fig. 10: Tapped densities of granulation batches 
 
. 
 
Fig. 11: Carr’s Index of granules 
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Fig. 12: Angle of repose of granule after granulation 
3.5.7 Bulkiness 
Granules prepared by FBG have higher bulkiness 
compare to the RMG, PMG and direct compression 
method. It may be due to the large amount of 
voidage is present in FBG. 
Table 2: Bulkiness of granules 
Granulation 
batches 
P2 R2 F2 D1 
Bulkiness 1.549 1.760 3.225 1.883 
3.5.8 Porosity of granules 
Granules prepared by FBG was porous than that of 
PMG and RMG. It may be due to the consolidation 
time was limited to granule drying time, which was 
of order of second, rather than minutes. Thus 
process changes that reduce drying time (higher 
bed temperature, lower liquid flow rate, and 
smaller drop size) will decreases granule density 
(increase granule porosity). Granules prepared by 
RMG showed lower porosity results in increased 
granule strength.  
Table 3: Porosity of granules 
 
Granulation 
batches 
P2 R2 F2 D1 
Porosity (%) 16.4 15.9 17.3 15.9 
3.5.9 Kawakita Plot 
The value of ‘a’ was least, and ‘b’ was maximum 
indicating good flowability. The value of ‘a’ 
indicated compressibility or densification due to 
tapping and ‘b’ as rate of achieving final packing. 
Figure 21 showed the kawakita plots for Diclofenac 
sodium granules containing selected diluents and 
PVP as binder, where a fairly linear relationship 
between N/C and N is obtained at all compression 
pressures used with correlation coefficient ≥ 0.99 
for all the formulations, and hence, the equation 
can be used to predict the densification 
mechanisms Values of 1/b and 1/ab were obtained 
from the slope and intercept of the plots 
respectively. It was observed from Table 11(which 
showed the Kawakita constants) that values of ‘a’ 
were smaller in the formulations with FBG than in 
the formulations with DC, PMG and RMG 
implying that the better the fluidity of the FBG. 
From Kawakita analysis, it was found that FBG 
granules densified the least (small compressible 
value) but attained the final packing state more 
slowly than DC formulation. The lower values of a 
and 1/b for the FBG granule formulation indicate 
better flowability and lesser cohesiveness than the 
direct compression formulation. 
 
 
Fig. 13: Kawakita plot 
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3.6 Formulation of Diclofenac sodium tablet 
Tablets were prepared by addition of 0.5% Mg-
stearate into the prepared granules. Tablets were 
prepared by wet granulation method and direct 
compression method. 
 
.7 Compaction Studies 
Heckel and walker plot was used determine the 
compressibility of granules. 
 
3.7.1 Heckel plot 
K represents the Heckel coefficient (slope of the 
Heckel plot) and mPy represents yield pressure as 
its inverse value. A (y-intercept) are regression 
coefficients of the linear portion of the curve. The 
FBG mixture is most compressible, with Py (for 
F2) 1.1748 followed by the PMG, RMG and DC 
mixtures  have Py  2.0967, 2.1610,  1.7921 
respectively, Low value of py indicates faster onset 
of plastic deformation. 
 
Heckel data for DC formulation and granule show 
no linearity at the early stages of compression due 
to particle rearrangement and the initial 
fragmentation. The higher value of intercept (A) 
for granules implies a higher degree of 
fragmentation than for DC formulation. When the 
compression pressure was increased, the granules 
showed plastic deformation. Materials with higher 
k values undergo more plastic flow and such 
materials often form strong tablets at relatively low 
compaction force. Crushing strength of tablets 
correlated with the values of k; Increased the slope 
value increased degree of plasticity and better 
compressibility formed. Here FBG have higher k 
values compare to the PMG, RMG and DC 
method. FBG mixture has excellent compressibility 
it may be due to its higher porosity to compare 
PMG, RMG and direct compression method.  It 
was evident that the achieved linearity of the 
Heckel curves was satisfactory, as demonstrated by 
high values of R2 ≥0.971. The best linearity was 
observed in the FBG mixture. The FBG mixture 
was most compressible. 
 
The tableting mixture density obviously plays an 
important role in powder compressibility. Usually, 
powders were more porous are considered more 
compressible. For instance, if the porosity of two 
mixtures of the same material is equal the mixture 
with lower bulk and/or tapped density was likely to 
be more compressible. This positive relationship 
was observed between the tapped densities and the 
Heckel coefficients of the mixtures studied. 
 
Fig. 14: A positive correlation between the tapped densities of tableting   mixtures and their Heckel 
coefficients (K). 
3.7.2 Walker plot: 
The Walker plots of compression for the respective 
mixtures showed even better linearity compared to 
the Heckel plot. The Walker model once again 
proved that FBG was most compressible mixture 
with w of 24.9 PMG, RMG and DC mixtures 
considerably lower compressibility measured. 
These results demonstrate exactly the same order of 
compressibility as the Heckel model and the 
positive correlation between these two methods 
that was observed. It was important to emphasize 
the Walker model’s slightly better discriminative 
power over the Heckel model to differentiate 
tableting mixture compressibility. 
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Fig. 15: A typical Walker plot: PMG mixture prepared by PMG and RMG mixture prepared by RMG 
 
 
3.8  Evaluation of tablets: 
Tablet for all the formulation were evaluted for 
parameter such as thickness, hardness, weight 
variation, drug content and friability. Results are 
summarised in Table 4. 
 
3.8.1 Thickness 
Thickness of tablet within the priscribed limit. 
 
3.8.2 Hardness 
FBG higher hardness compare to the RMG, PMG 
and DC method. FBG shows higher hardness at 
low compression force compare to RMG, PMG and 
DC method but all hardness of tablets are within 
the prescribed limit. 
 
3.8.3 Weight variation test 
In weight variation test used to show the content 
uniformity of drugs. Average weight in mg (within 
the limit ±5%). Average percentage deviation of all 
formulations was found to be within limit and 
hence, all formulations passed the test for 
uniformity of weight as per official requirement. 
 
3.8.4 Friability test 
Friability of FBG was less than RMG, PMG and 
DC method. DC method shows higher friability 
compare to the wet granulation method. But 
percentage friability for all formulation was below 
1%, indicating that friability was within the 
prescribed limits. 
 
3.8.5 Drug content 
All formulation showed good uniformity in drug 
content among different formulations of tablet and 
percentage of drug content was within the 
prescribed limit. 
 
3.8.6 Disintegration test for tablet: 
Here In wet granulation method FBG tablet 
disintegrate fast in phosphate buffer pH 6.8 
compare to tablet produced by the RMG and PMG. 
But direct compression method shows faster 
disintegration compared to the wet granulation 
method. 
All the tablet formulation showed acceptable 
properties and complied with specification for 
weight variation, drug content, hardness, friability 
and disintegration. 
 
3.8.7 In- vitro drug release studies: 
Direct compression shows fast release compare to 
wet granulation method. In wet granulation FBG 
showed fast release compared to PMG and RMG. 
Table 4: Evalution of tablet parameters 
Sr. 
No. 
Parameter PMG RMG FBG DC 
1 Thickness* (mm) ± SD 4±0.05 4.1±0.04 4±0.01 4.2±0.04 
2 
Hardness*(Kg/cm2) ± 
SD 
4.8±0.115 4.6±0.115 5.0±0.115 4.8±0.115 
3 
Average weight* (mg) 
± SD 
Within the limits 
(±5%) 
Within the limits 
(±5%) 
Within the 
limits (±5%) 
Within the 
limits (±5%) 
4 Friability* (%) ± SD 0.53±0.05 0.68±0.02 0.46±0.01 0.78±0.02 
5 
Drug content* (%)± 
SD 
98.73±1.96 99.27±08 100±0.66 98.48±2.44 
6 
Disintigration test 
(min) 
(Average time taken) 
15 14 13 12 
7 Dissolution test 
Mean cumulative 
% release within 
60 minutes 
(92.2%) 
Mean 
cumulative % 
release within 60 
minutes (90.0%) 
Mean 
cumulative % 
release within 
60 minutes 
(96.7%) 
Mean 
cumulative % 
release within 
60 minutes 
(97.0%) 
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Fig.16: Dissolution profile of formulation P2, R2, F2 and D2 
 
 
 
Fig. 17:Dissolution profile of stability study of F2 batch 
 
3.8.8 Drug Release Kinetic 
All the formulation were studied for kinetic release 
like different mechanisms first order, Higuchi, 
Hixon crowell, zero order or Korsmer- Peppas 
model. From this study it was observed that from 
all formulation batch showed more best fitted 
model was Korsymer- Peppas model except DC 
method 
 
3.9 Accelerated Stability Study 
Table 36 showed that there was no considerable 
change in thickness, hardness and drug content of 
F2 formulation before and after accelerated 
stability study. Also  there was no significant 
difference found between dissolution profile of F2 
formulation before  and after stability. Hence tablet 
prepared by wet granulation to be stable. 
 
CONCLUSION: 
Various powder agglomeration processes have a 
great impact on the tablet compaction process. In 
order to investigate the loss on drying,  particle size 
distribution, porosity, spherisity, bulk density, flow 
property and compressibility, compatibility, tablet 
properties (weight uniformity, hardness, friability 
and disintegration, drug content, dissolution) and 
accelerated stability study of Diclofenac sodium 
tablet for that complex tableting mixtures of 
Diclofenac sodium  were precisely characterized. 
FBG show loss on drying within prescribed limit. 
Fluid bed granulation processes resulted in the 
formation of narrower particle size distribution, 
high porosity, spherisity, lower bulk density 
compared to PMG, RMG in which a higher amount 
of fines 29.12% was produced, something that is 
typically observed in PMG processes. The flow 
properties of Fluid bed granulated mixtures were 
superior shown by the kawakita equation; however, 
all tableting mixtures had acceptable flow 
properties for tablet production on a KBr tablet 
press machine. Tablets produced from Fluid be 
granulated mixtures had lower friability at all 
compression pressures. The results of 
compressibility studies using Walker and Heckel 
analyses show that the FBG mixture has the best 
compressibility and Leuenberger equation show 
that FBG mixtuer has the best 
compactibilityfollowed by the PMG, RMG and DC 
mixtures, which are comparable to each other. All 
the tablet formulations showed acceptable 
properties and complied with specification for 
weight variation, drug content, hardness, friability 
and disintegration.  Fluid be granulated mixtures 
had lower friability   compare to the other batches. 
In case of in- vitro drug release for wet granulation 
techniques FBG showed faster drug release 
compare to the RMG and PMG. But in- vitro drug 
release for FBG compare with DC method. The DC 
method showed faster drug release compare to the 
FBG. In case of Accelerated stability study of FBG 
there was no considerable change in physical 
appereance, thickness, hardness, drug content and 
In- vitro drug release. Finally by evaluation of 
different granulation properties and tablet 
properties, it was conclude that FBG is best wet 
granulation method compare to RMG, PMG and 
DC method. 
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